Ducommun (NYSE:DCO – Get Free Report) and PMGC (NASDAQ:ELAB – Get Free Report) are both industrials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.
Volatility and Risk
Ducommun has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, PMGC has a beta of -0.27, meaning that its share price is 127% less volatile than the S&P 500.
Profitability
This table compares Ducommun and PMGC’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ducommun | -3.10% | 9.20% | 5.07% |
| PMGC | -522.92% | -118.83% | -60.03% |
Valuation & Earnings
This table compares Ducommun and PMGC”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ducommun | $824.73 million | 2.63 | -$37.35 million | $3.32 | 43.20 |
| PMGC | $590,000.00 | 2.20 | -$7.75 million | ($1,305.96) | -0.00 |
PMGC has lower revenue, but higher earnings than Ducommun. PMGC is trading at a lower price-to-earnings ratio than Ducommun, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent recommendations for Ducommun and PMGC, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ducommun | 0 | 3 | 5 | 0 | 2.62 |
| PMGC | 1 | 0 | 0 | 0 | 1.00 |
Ducommun currently has a consensus price target of $196.67, indicating a potential upside of 37.13%. Given Ducommun’s stronger consensus rating and higher possible upside, research analysts plainly believe Ducommun is more favorable than PMGC.
Institutional and Insider Ownership
92.2% of Ducommun shares are owned by institutional investors. Comparatively, 22.2% of PMGC shares are owned by institutional investors. 5.0% of Ducommun shares are owned by company insiders. Comparatively, 0.0% of PMGC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Ducommun beats PMGC on 13 of the 14 factors compared between the two stocks.
About Ducommun
Ducommun Inc. is a provider of engineering and manufacturing services for the aerospace, defense and industrial markets. Founded in 1849 in Los Angeles, the company began as a hardware business before expanding into manufacturing components for aerospace and defense applications. Ducommun operates through its Electronic Systems and Structural Systems businesses. Its products and services include electronic and electromechanical assemblies, circuit-card assemblies, interconnect systems, precision-machined parts, structural components and composite assemblies.
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Receive News & Ratings for Ducommun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun and related companies with MarketBeat.com's FREE daily email newsletter.
